Skip to main content
. 2009 Sep 1;2009:861481. doi: 10.1155/2009/861481

Table 4.

Self-reported infections and their severity* within the six months prior to commencing bDMARDs (n = 158).

Mild Moderate Severe
Skin or nail 16 (10.1) 14 (8.9) 8 (5.1)
Eye, ear, nose, throat 9 (5.7) 23 (14.6) 4 (2.5)
Heart 1 (0.6) 1 (0.6) 0 (0)
Chest or lung 2 (1.3) 7 (4.4) 1 (0.6)
Stomach, gut, gall bladder, liver 2 (1.3) 2 (1.3) 3 (1.9)
Kidney, bladder, urine 3 (1.9) 12 (7.6) 7 (4.4)
Bone, joint, muscle 0 (0) 5 (3.2) 6 (3.8)
Artificial joint 0 (0) 0 (0) 1 (0.6)
Brain or spinal cord 1 (0.6) 0 (0) 0 (0)
Blood 0 (0) 2 (1.3) 2 (1.3)
Viral 5 (3.2) 9 (5.7) 2 (1.3)
Other 0 (0) 2 (1.3) 4 (2.5)
Total infections 39 (24.7) 77 (48.7) 38 (24.0)

*Definitions of infection grades:

Mild: activities did not change because of complaint, did not see a doctor or require prescription treatment for the complaint;

Moderate: activities changed occasionally because of the complaint, saw a doctor and/or needed prescription medications to relieve the complaint;

Severe: caused a major change in activities, saw a doctor, required prescription medication which only provided partial relief; if a drug treatment was responsible it may have been stopped.